title: Effects of paroxetine and venlafaxine on immune parameters in patients with obsessive compulsive disorder.
abstract: BACKGROUND
  Obsessive-compulsive disorder (OCD) has been associated with an altered activity of the immune system. This study was carried out to investigate whether treatment with paroxetine and venlafaxine modifies the immune function in OCD and whether this modification is related to treatment outcome.
  
  
  METHODS
  Ex vivo production of TNF-alpha, IL-4, IL-6, IL-10, and IFN-gamma in whole blood cultures, and NK-cell activity and peripheral blood NK-cell-, monocytes-, T-cell-, and B-cell- percentages were measured in 42 outpatients with OCD who participated in a 12-week, double-blind SRI trial.
  
  
  RESULTS
  Paroxetine and venlafaxine treatment did not affect immune parameters and clinical response was not directly related to altered activity of the immune system. Responders, defined as having a >or=25% decrease on the Y-BOCS, differed from non-responders with regard to the change of TNF-alpha values.
  
  
  CONCLUSIONS
  The present results suggest that paroxetine and venlafaxine do not affect immune parameters and that clinical response is not related to altered activity of the immune system in OCD. Nonetheless, our data yielded interesting preliminary results that warrant further discussion and investigation.
authors.affiliation: Department of Psychiatry, UMC, Rudolf Magnus Institute of Neuroscience, B.01.206, P.O. Box 85500, 3508 GA Utrecht, The Netherlands. d.a.j.p.denys@azu.nl
authors.forename: Damiaan
authors.initials: D
authors.lastname: Denys
authors.forename: Sjoerd
authors.initials: S
authors.lastname: Fluitman
authors.forename: Annemieke
authors.initials: A
authors.lastname: Kavelaars
authors.forename: Cobi
authors.initials: C
authors.lastname: Heijnen
authors.forename: Herman G M
authors.initials: HG
authors.lastname: Westenberg
mesh_terms: D000328:Adult; D003511:Cyclohexanols / Q000494:pharmacology*; D016207:Cytokines / Q000097:blood / Q000187:drug effects*; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D007694:Killer Cells, Natural / Q000187:drug effects* / Q000276:immunology; D008297:Male; D008875:Middle Aged; D009771:Obsessive-Compulsive Disorder / Q000097:blood / Q000188:drug therapy* / Q000276:immunology*; D017374:Paroxetine / Q000494:pharmacology*; D017367:Selective Serotonin Reuptake Inhibitors / Q000494:pharmacology*; D018709:Statistics, Nonparametric; D014409:Tumor Necrosis Factor-alpha / Q000032:analysis / Q000187:drug effects; D000069470:Venlafaxine Hydrochloride
chemical_list: D003511:Cyclohexanols; D016207:Cytokines; D017374:Paroxetine; D017367:Selective Serotonin Reuptake Inhibitors; D014409:Tumor Necrosis Factor-alpha; D000069470:Venlafaxine Hydrochloride